Affordable Access

Publisher Website

Chemotherapeutic Candidate Inducing Immunological Death of Human Tumor Cell Lines

Authors
Journal
Immune Network
1598-2629
Publisher
Korean Association of Immunobiologists (KAMJE)
Publication Date
Volume
12
Issue
2
Identifiers
DOI: 10.4110/in.2012.12.2.66
Keywords
  • Brief Communication
Disciplines
  • Medicine

Abstract

The immunological death induction by EY-6 on the human tumor cell lines was screened. Human colon carcinoma (HCT15, HCT116), gastric carcinoma (MKN74, SNU668), and myeloma (KMS20, KMS26, KMS34) cells were died by EY-6 treatment with dose-dependent manner. CRT expression, a typical marker for the immunological death, was increased on the EY-6-treated colorectal and gastric cancer cells. Interestingly, the effects on the myeloma cell lines were complicated showing cell line dependent differential modulation. Cytokine secretion from the EY-6 treated tumor cells were dose and cell-dependent. IFN-γ and IL-12 secretion was increased in the treated cells (200% to over 1000% of non-treated control), except HCT116, SNU668 and KMS26 cells which their secretion was declined by EY-6. Data suggest the potential of EY-6 as a new type of immuno-chemotherapeutics inducing tumor-specific cell death. Further studies are planned to confirm the efficacy of EY-6 including in vivo study.

There are no comments yet on this publication. Be the first to share your thoughts.